656 related articles for article (PubMed ID: 12738712)
21. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors.
Hubbard WC; Alley MC; Gray GN; Green KC; McLemore TL; Boyd MR
Cancer Res; 1989 Feb; 49(4):826-32. PubMed ID: 2536293
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J
Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma.
Saukkonen K; Nieminen O; van Rees B; Vilkki S; Härkönen M; Juhola M; Mecklin JP; Sipponen P; Ristimäki A
Clin Cancer Res; 2001 Jul; 7(7):1923-31. PubMed ID: 11448905
[TBL] [Abstract][Full Text] [Related]
25. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
26. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
27. Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers.
Abd-El-Aleem SA; Ferguson MW; Appleton I; Bhowmick A; McCollum CN; Ireland GW
J Pathol; 2001 Dec; 195(5):616-23. PubMed ID: 11745699
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer.
Bing RJ; Miyataka M; Rich KA; Hanson N; Wang X; Slosser HD; Shi SR
Clin Cancer Res; 2001 Nov; 7(11):3385-92. PubMed ID: 11705852
[TBL] [Abstract][Full Text] [Related]
29. [A study on cyclooxygenase-2 protein expression and vasculature during experimental rat lung carcinogenesis].
Li HG; Yu LY; Liu MQ; Chen HL; Zhang YX; Liu X; Tang ZJ; Xia D; Zou ZY
Ai Zheng; 2002 Jun; 21(6):605-9. PubMed ID: 12452059
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation.
El-Bayoumy K; Rose DP; Papanikolaou N; Leszczynska J; Swamy MV; Rao CV
Int J Oncol; 2002 Mar; 20(3):557-61. PubMed ID: 11836568
[TBL] [Abstract][Full Text] [Related]
31. Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells.
Heuze-Vourc'h N; Zhu L; Krysan K; Batra RK; Sharma S; Dubinett SM
Cancer Res; 2003 Feb; 63(4):766-70. PubMed ID: 12591723
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
[TBL] [Abstract][Full Text] [Related]
33. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cyclo-oxygenase-2.
Stack E; DuBois RN
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):787-800. PubMed ID: 11566041
[TBL] [Abstract][Full Text] [Related]
35. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 inhibitors in lung cancer.
Ramalingam S; Belani CP
Clin Lung Cancer; 2004 Jan; 5(4):245-53. PubMed ID: 14967078
[TBL] [Abstract][Full Text] [Related]
38. COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
Yamaguchi NH; Lichtenfels AJ; Demarchi LM; da Silva AP; Garippo AL; Alves VF; Michelin C; Azevedo PM; Moya T; Takagaki T; Saldiva PH; Vollmer RT; Capelozzi VL
Am J Clin Pathol; 2004 Jan; 121(1):78-86. PubMed ID: 14750244
[TBL] [Abstract][Full Text] [Related]
39. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
Shariat SF; Matsumoto K; Kim J; Ayala GE; Zhou JH; Jian W; Benedict WF; Lerner S
J Urol; 2003 Sep; 170(3):985-9. PubMed ID: 12913755
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
Byeon JS; Jung HY; Lee YJ; Lee D; Lee GH; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI; Kim JS
J Gastroenterol Hepatol; 2004 Jun; 19(6):648-54. PubMed ID: 15151619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
